Palliative urinary diversion in patients with advanced pelvic malignancy

Area of Science:

• Urology
• Oncology
• Nephrology

Background:

• Advanced pelvic malignancy frequently causes bilateral ureteral obstruction.
• Urinary diversion is a critical intervention for managing such cases.
• Understanding survival patterns post-diversion is essential for patient care.

Purpose of the Study:

• To analyze survival outcomes in patients with advanced pelvic malignancy and bilateral ureteral obstruction treated with urinary diversion.
• To identify factors influencing survival, including age, prior treatment, and renal function.
• To establish guidelines for selecting patients who may benefit from urinary diversion.

Main Methods:

• Retrospective review of 90 patients with advanced pelvic malignancy and bilateral ureteral obstruction.
• Analysis of survival data based on patient demographics, malignancy characteristics, and treatment history.
• Correlation of survival length with cell type, prior treatment, renal decompensation, and age groups.

Main Results:

• No significant correlation between cell type, prior treatment, or renal decompensation and survival length.
• Youngest age group (27-49 years) exhibited significantly shorter survival.
• Patients with prior treatment showed longer median survival with increased time from malignancy diagnosis to diversion.
• 30 patients survived ≥6 months, spending an average of 14% of remaining life in hospital.

Conclusions:

• Urinary diversion outcomes in advanced pelvic malignancy are complex and not solely dependent on tumor biology or renal status.
• Age is a significant prognostic factor, with younger patients facing poorer survival.
• Optimizing the timing of urinary diversion in previously treated patients may improve survival outcomes.
• Guidelines for patient selection are proposed to enhance the benefits of urinary diversion.